Multi-Site, Post-Market Study of the ICONACY I-Hip System

NCT02131389 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2014-05-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use and efficacy of the I-Hip for primary total hip replacement surgery.

Conditions

  • Degenerative Joint Disease

Interventions

DEVICE

Iconacy Hip System

Sponsors & Collaborators

  • Iconacy Orthopedic Implants, LLC.

    lead INDUSTRY

Principal Investigators

  • Donald L Pomeroy, MD · Pomeroy & Rhoads Orthopaedics, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02131389 on ClinicalTrials.gov